Literature DB >> 19395477

Peroxisome proliferator-activated receptor-gamma abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator.

Asish K Ghosh1, Swati Bhattacharyya, Jun Wei, Suyeon Kim, Yaacov Barak, Yasuji Mori, John Varga.   

Abstract

Ligands of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) abrogate the stimulation of collagen gene transcription induced by transforming growth factor-beta (TGF-beta). Here, we delineate the mechanisms underlying this important novel physiological function for PPAR-gamma in connective tissue homeostasis. First, we demonstrated that antagonistic regulation of TGF-beta activity by PPAR-gamma ligands involves cellular PPAR-gamma, since 15-deoxy-Delta12,14-prostaglandin J(2) (15d-PGJ(2)) failed to block TGF-beta-induced responses in either primary cultures of PPAR-gamma-null murine embryonic fibroblasts, or in normal human skin fibroblasts with RNAi-mediated knockdown of PPAR-gamma. Next, we examined the molecular basis underlying the abrogation of TGF-beta signaling by PPAR-gamma in normal human fibroblasts in culture. The results demonstrated that Smad-dependent transcriptional responses were blocked by PPAR-gamma without preventing Smad2/3 activation. In contrast, the interaction between activated Smad2/3 and the transcriptional coactivator and histone acetyltransferase p300 induced by TGF-beta, and the accumulation of p300 on consensus Smad-binding DNA sequences and histone H4 hyperacetylation at the COL1A2 locus, were all prevented by PPAR-gamma. Wild-type p300, but not a mutant form of p300 lacking functional histone acetyltransferase, was able to restore TGF-beta-induced stimulation of COL1A2 in the presence of PPAR-gamma ligands. Collectively, these results indicate that PPAR-gamma blocked Smad-mediated transcriptional responses by preventing p300 recruitment and histone H4 hyperacetylation, resulting in the inhibition of TGF-beta-induced collagen gene expression. Pharmacological activation of PPAR-gamma thus may represent a novel therapeutic approach to target p300-dependent TGF-beta profibrotic responses such as stimulation of collagen gene expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19395477      PMCID: PMC2735362          DOI: 10.1096/fj.08-128736

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  62 in total

1.  PPAR gamma is required for placental, cardiac, and adipose tissue development.

Authors:  Y Barak; M C Nelson; E S Ong; Y Z Jones; P Ruiz-Lozano; K R Chien; A Koder; R M Evans
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

Review 2.  Smad transcription factors.

Authors:  Joan Massagué; Joan Seoane; David Wotton
Journal:  Genes Dev       Date:  2005-12-01       Impact factor: 11.361

3.  Smads orchestrate specific histone modifications and chromatin remodeling to activate transcription.

Authors:  Sarah Ross; Edwin Cheung; Thodoris G Petrakis; Michael Howell; W Lee Kraus; Caroline S Hill
Journal:  EMBO J       Date:  2006-09-21       Impact factor: 11.598

Review 4.  Transcriptional regulation of the human alpha2(I) collagen gene (COL1A2), an informative model system to study fibrotic diseases.

Authors:  Francesco Ramirez; Shizuko Tanaka; George Bou-Gharios
Journal:  Matrix Biol       Date:  2006-05-23       Impact factor: 11.583

5.  Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation.

Authors:  Feng Zheng; Alessia Fornoni; Sharon J Elliot; Youfei Guan; Matthew D Breyer; Liliane J Striker; Gary E Striker
Journal:  Am J Physiol Renal Physiol       Date:  2002-04

6.  Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells.

Authors:  X Liu; Y Sun; S N Constantinescu; E Karam; R A Weinberg; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

7.  p300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively.

Authors:  L Gelman; G Zhou; L Fajas; E Raspé; J C Fruchart; J Auwerx
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

8.  Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators.

Authors:  Y Kodera; K Takeyama; A Murayama; M Suzawa; Y Masuhiro; S Kato
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

9.  Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells - role of PPAR-gamma in vascular fibrosis.

Authors:  Deng-Feng Gao; Xiao-Lin Niu; Guang-Hua Hao; Ning Peng; Jin Wei; Ning Ning; Nan-Ping Wang
Journal:  Biochem Pharmacol       Date:  2006-09-23       Impact factor: 5.858

10.  Constitutive Smad signaling and Smad-dependent collagen gene expression in mouse embryonic fibroblasts lacking peroxisome proliferator-activated receptor-gamma.

Authors:  Asish K Ghosh; Jun Wei; Minghua Wu; John Varga
Journal:  Biochem Biophys Res Commun       Date:  2008-07-15       Impact factor: 3.575

View more
  49 in total

Review 1.  Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.

Authors:  Swati Bhattacharyya; Jun Wei; John Varga
Journal:  Nat Rev Rheumatol       Date:  2011-10-25       Impact factor: 20.543

Review 2.  Fibrosis--a lethal component of systemic sclerosis.

Authors:  Yuen Yee Ho; David Lagares; Andrew M Tager; Mohit Kapoor
Journal:  Nat Rev Rheumatol       Date:  2014-04-22       Impact factor: 20.543

Review 3.  Molecular determinants of mesenchymal cell activation in fibroproliferative diseases.

Authors:  Loka R Penke; Marc Peters-Golden
Journal:  Cell Mol Life Sci       Date:  2019-09-28       Impact factor: 9.261

4.  Possible strategies for anti-fibrotic drug intervention in scleroderma.

Authors:  Andrew Leask
Journal:  J Cell Commun Signal       Date:  2011-01-29       Impact factor: 5.782

5.  VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways.

Authors:  Carmen Del Rio; Irene Cantarero; Belén Palomares; María Gómez-Cañas; Javier Fernández-Ruiz; Carolina Pavicic; Adela García-Martín; Maria Luz Bellido; Rafaela Ortega-Castro; Carlos Pérez-Sánchez; Chary López-Pedrera; Giovanni Appendino; Marco A Calzado; Eduardo Muñoz
Journal:  Br J Pharmacol       Date:  2018-08-23       Impact factor: 8.739

6.  HDAC8 inhibition ameliorates pulmonary fibrosis.

Authors:  Shigeki Saito; Yan Zhuang; Takayoshi Suzuki; Yosuke Ota; Marjorie E Bateman; Ala L Alkhatib; Gilbert F Morris; Joseph A Lasky
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-10-25       Impact factor: 5.464

7.  The transcriptional cofactor nab2 is induced by tgf-Beta and suppresses fibroblast activation: physiological roles and impaired expression in scleroderma.

Authors:  Swati Bhattacharyya; Jun Wei; Denisa S Melichian; Jeffrey Milbrandt; Kazuhiko Takehara; John Varga
Journal:  PLoS One       Date:  2009-10-26       Impact factor: 3.240

8.  Effects of PPAR gamma ligands on TGF-beta1-induced epithelial-mesenchymal transition in alveolar epithelial cells.

Authors:  Xiahui Tan; Hayat Dagher; Craig A Hutton; Jane E Bourke
Journal:  Respir Res       Date:  2010-02-23

9.  PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis.

Authors:  Jun Wei; Asish K Ghosh; Jennifer L Sargent; Kazuhiro Komura; Minghua Wu; Qi-Quan Huang; Manu Jain; Michael L Whitfield; Carol Feghali-Bostwick; John Varga
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240

Review 10.  Noncanonical transforming growth factor beta signaling in scleroderma fibrosis.

Authors:  Maria Trojanowska
Journal:  Curr Opin Rheumatol       Date:  2009-11       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.